| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193276 | Annals of Allergy, Asthma & Immunology | 2007 | 8 Pages |
Abstract
In this study, intranasal ciclesonide, 200 μg once daily, was safe and effective for the long-term treatment of PAR, with no evidence of tachyphylaxis.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Paul MD, Sudeesha PhD, David L. MD, Bruce M. MD, Gordon MD, Nancy MS, Tushar MD,